| Hangzhou Molcore Biopharmatech Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8102-5280 | |||
![]() |
sales@molcore.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2010 | ||||
| chemBlink standard supplier since 2017 | ||||
| Classification | Biochemical >> Inhibitor >> PI3K/Akt/mTOR inhibitor (PI3K/Akt/mTOR) >> Akt inhibitor |
|---|---|
| Name | Afuresertib |
| Synonyms | N-[(1S)-2-Amino-1-[(3-fluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide; GSK 2110183C |
| Molecular Structure | ![]() |
| Molecular Formula | C18H17Cl2FN4OS |
| Molecular Weight | 427.32 |
| CAS Registry Number | 1047644-62-1 |
| Solubility | Insoluble (8.1E-4 g/L) (25 ºC), Calc.* |
|---|---|
| Density | 1.49±0.1 g/cm3 (20 ºC 760 Torr), Calc.* |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2016 ACD/Labs) |
| SDS | Available |
|---|---|
| Market Analysis Reports |
| List of Reports Available for Afuresertib |